Stay updated on Mirvetuximab Soravtansine Clinical Trial
Sign up to get notified when there's something new on the Mirvetuximab Soravtansine Clinical Trial page.

Latest updates to the Mirvetuximab Soravtansine Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe study's Locations section was updated with new site listings across multiple US states and Canadian provinces. Several previously listed locations were removed.SummaryDifference1%

- Check26 days agoNo Change Detected
- Check48 days agoChange DetectedRevision: v3.3.2 has been added and Revision: v3.2.0 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedRemoved a government funding notice from the page. Core study details, inclusion criteria, and listed locations remain unchanged.SummaryDifference0.3%

- Check76 days agoChange DetectedNo significant additions or deletions were detected on the Study Details page for NCT01609556 between the screenshots; the inclusion/exclusion criteria, study design, and listed locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check98 days agoChange DetectedSignificant update: new operating-status notice and version 3.2.0, replacing v3.1.0; core content about current operations and where to check status has been added.SummaryDifference2%

- Check105 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.0%

Stay in the know with updates to Mirvetuximab Soravtansine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Soravtansine Clinical Trial page.